Myriad Genetics
MYGN
MYGN
246 hedge funds and large institutions have $2.48B invested in Myriad Genetics in 2024 Q3 according to their latest regulatory filings, with 47 funds opening new positions, 86 increasing their positions, 72 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
10% more capital invested
Capital invested by funds: $2.26B → $2.48B (+$227M)
10% more funds holding
Funds holding: 224 → 246 (+22)
2.08% less ownership
Funds ownership: 101.97% → 99.88% (-2.1%)
Holders
246
Holding in Top 10
2
Calls
$3.04M
Puts
$1.24M
Top Buyers
| 1 | +$36.3M | |
| 2 | +$21.3M | |
| 3 | +$12.1M | |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$12M |
| 5 |
ITP
Iron Triangle Partners
Cos Cob,
Connecticut
|
+$11M |
Top Sellers
| 1 | -$68.1M | |
| 2 | -$46.5M | |
| 3 | -$42.5M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$42.3M |
| 5 |
Morgan Stanley
New York
|
-$13.5M |